Total Funding
59
56
Total FundingSeries B raised
Growth Score
-1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39711
Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.
- Stephanie George: CFO and Director of Programs
- Murali Prahalad: President and CEOPast Role: Epic Sciences, CEO & President
About the Company
Iridia is a nanotechnology company that specializes in biochemistry, molecular biology, and DNA. It develops the world’s first commercially-attractive, DNA-based data storage solution that combines DNA polymer synthesis technology, electronic nano-switches, and semiconductor fabrication technologies.
Iridia developed a highly-parallel format to
enable an array of nanomodules with the potential to store data at exceptionally high density.
The company was founded in 2016 and headquartered in California, United States.
